Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Mikio, Tomita"'
Publikováno v:
Biological and Pharmaceutical Bulletin. 45:1036-1042
Autor:
Mikio Tomita, Makoto Ishii, Momona Sasaki, Takuo Ogihara, Kaori Morimoto, Erika Oikawa, Tatsuro Kikuchi, Maho Abe
Publikováno v:
Biologicalpharmaceutical bulletin. 44(5)
Alogliptin (ALG), an inhibitor of dipeptidylpeptidase-4, is used in the management of type 2 diabetes mellitus, and has a high absorption rate (>60-71%), despite its low lipophilicity (logP=-1.4). Here, we aimed to clarify the mechanism of its intest
Publikováno v:
Biopharmaceuticsdrug dispositionREFERENCES. 41(3)
In the colon of patients with ulcerative colitis (UC), decreased function of the paracellular barrier, especially hypofunction of the tight junction, is associated with pathological conditions. However, there has been no report to date on the functio
Autor:
Toshio Oda, Jun Aketagawa, Yasuhiko Ito, Shohei Ouchi, Mikio Tomita, Yusuke Takizawa, Masahiro Hayashi, Aiko Iida
Publikováno v:
European journal of drug metabolism and pharmacokinetics. 43(6)
The Editor-in-Chief has retracted this article [1] based on an investigation by the Ministry of Education, Culture, Sports, Science and Technology, Japan, which found that the article contained overlap with a previously published article by Kalitsky-
Autor:
Masanari Miyamoto, Yuuta Tominaga, Yoshimi Sano, Kentaro Yano, Shota Kashiwagura, Yuta Agatsuma, Kaori Morimoto, Takuo Ogihara, Mikio Tomita, Akira Takahashi, Chihaya Kakinuma
Publikováno v:
Biopharmaceuticsdrug disposition. 39(7)
Indoxyl sulfate (IS) is a protein-bound uremic toxin that progressively accumulates in plasma during chronic kidney disease (CKD), and its accumulation is associated with the progression of CKD. This study examined the intestinal secretion of IS usin
Autor:
Mikio Tomita, Yusuke Takizawa, Yasuhiko Ito, Aiko Iida, Toshio Oda, Jun Aketagawa, Masahiro Hayashi, Shohei Ouchi
Publikováno v:
European Journal of Drug Metabolism and Pharmacokinetics. 40:29-38
Infection and inflammation suppress the expression and activity of several drug transporters in liver. In the intestine, P-glycoprotein (P-gp/MDR1), multidrug resistance-associated protein 2 (MRP2), and breast cancer resistance protein (BCRP) are imp
Autor:
Mikio, TOMITA
Publikováno v:
東北薬科大学研究誌. 59:1-11
Autor:
Megumi Hatanaka, Mariko Nakaike, Mikio Tomita, Yusuke Takizawa, Atsushi Kanbayashi, Ayako Tanaka, Masahiro Hayashi, Tomomi Kai, Hiroyuki Murata
Publikováno v:
International Journal of Pharmaceutics. 428:33-38
Infection and inflammation suppress the expression and activity of several drug transporters in the liver. In the intestine, P-glycoprotein (PGP/mdr1) and the multidrug resistance-associated protein 2 (MRP2) are important barriers to the absorption o
Publikováno v:
European Journal of Pharmaceutical Sciences. 42:246-252
Ischemia/reperfusion (I/R) injury must be overcome for successful small intestinal transplantation. During intestinal I/R, the expression level of nitric oxide (NO) is increased, and vermiculation of the mucosal tract is induced by NO. Although NO ha
Autor:
Yusuke Takizawa, Naomi Kamiya, Mikio Tomita, Masahiro Hayashi, Takuya Kitazato, Haruka Ishizaka
Publikováno v:
Biological and Pharmaceutical Bulletin. 34:1737-1743
Ischemia/reperfusion (I/R) injury is induced by reactive oxygen species (ROS). During intestinal I/R, the amount of nitric oxide (NO), which is a ROS, is increased. In this study, we examined the protection against I/R injury by inhibition of NO gene